About half of clinical trial results are never published, leaving valuable information unavailable. Every year, thousands of Canadians sign up to participate in clinical trials, offering their bodies to further the development of important medical advances...
[caption id="attachment_1352" align="alignleft" width="200"] Dr. Tom Perry, MD, PhD, Internist and Clinical Pharmacologist, Chair of the Education Working Group of the UBC Therapeutics Initiative[/caption] [caption id="attachment_3491" align="alignright" width="300"] Dr. Aaron Tejani, PharmD, Clinical Pharmacist and active...
Glucose lowering drugs are commonly prescribed in British Columbia, and 44% of adults with type 2 diabetes are receiving more than one drug (see Table). Annual spending on non-insulin glucose lowering drugs in Canada was $748 million in 2013.1...
Six previous Therapeutics Letters reported information about the benefits and harms of different proton pump inhibitors (PPIs).1-6 These drugs work by irreversibly inhibiting gastric H+K+ ATPase (the proton pump) in the stomach. They inhibit both basal and stimulated acid secretion...